Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement.

ABSTRACT:

Purpose

Most patients with cancer do not participate in a clinical trial. Understanding clinical participation rates, and the barriers and motivators that influence participation may help identify opportunities for improvement in accrual.

Methods

A cross-sectional analysis of cancer survivors was conducted using the Health Information National Trends Survey (HINTS) administered in 2020. Primary outcome was clinical trial participation amongst patients with cancer. Secondary outcomes were motivators and barriers to influence clinical trial participation. Logistic regression was employed to assess the association of clinical trials being discussed as a cancer treatment option with social determinants.

Results

Six hundred and eighteen respondents (weighted population est

SUBMITTER: Feuer ZS 

PROVIDER: S-EPMC12314213 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature